Cargando…

The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis

INTRODUCTION: Recent studies in septic patients showed that adverse effects of hydroxyethyl starches (HESs) possibly outweigh their benefits in severely impaired physiological haemostasis. It remains unclear whether this also applies to patient populations that are less vulnerable. In this meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Matthias, Fellahi, Jean-Luc, Chappell, Daniel, Kurz, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301454/
https://www.ncbi.nlm.nih.gov/pubmed/25475406
http://dx.doi.org/10.1186/s13054-014-0656-0
_version_ 1782353642646405120
author Jacob, Matthias
Fellahi, Jean-Luc
Chappell, Daniel
Kurz, Andrea
author_facet Jacob, Matthias
Fellahi, Jean-Luc
Chappell, Daniel
Kurz, Andrea
author_sort Jacob, Matthias
collection PubMed
description INTRODUCTION: Recent studies in septic patients showed that adverse effects of hydroxyethyl starches (HESs) possibly outweigh their benefits in severely impaired physiological haemostasis. It remains unclear whether this also applies to patient populations that are less vulnerable. In this meta-analysis, we evaluated the impact of various HES generations on safety and efficacy endpoints in patients undergoing cardiac surgery. METHODS: We searched the PubMed, Embase and Cochrane Central Register of Controlled Trials databases for randomised controlled trials (RCTs) in the English or German language comparing the use of HES to any other colloid or crystalloid during open heart surgery. RESULTS: Blood loss and transfusion requirements were higher for older starches with mean molecular weights more than 200 kDa compared to other volume substitutes. In contrast, this effect was not observed with latest-generation tetrastarches (130/0.4), which performed even better when compared to albumin (blood loss of tetrastarch versus albumin: standardised mean difference (SMD), −0.34; 95% CI, −0.63, −0.05; P = 0.02; versus gelatin: SMD, −0.06; 95% CI, −0.20, 0.08; P = 0.39; versus crystalloids: SMD, −0.05; 95% CI, −0.20, 0.10; P = 0.54). Similar results were found for transfusion needs. Lengths of stay in the intensive care unit or hospital were significantly shorter with tetrastarches compared to gelatin (intensive care unit: SMD, −0.10; 95% CI, −0.15, −0.05; P = 0.0002) and crystalloids (hospital: SMD, −0.52; 95% CI, −0.90, −0.14; P = 0.007). CONCLUSIONS: In this meta-analysis of RCTs, we could not identify safety issues with tetrastarches compared with other colloid or crystalloid solutions in terms of blood loss, transfusion requirements or hospital length of stay in patients undergoing cardiac surgery. The safety data on coagulation with older starches raise some issues that need to be addressed in future trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-014-0656-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4301454
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43014542015-01-22 The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis Jacob, Matthias Fellahi, Jean-Luc Chappell, Daniel Kurz, Andrea Crit Care Research INTRODUCTION: Recent studies in septic patients showed that adverse effects of hydroxyethyl starches (HESs) possibly outweigh their benefits in severely impaired physiological haemostasis. It remains unclear whether this also applies to patient populations that are less vulnerable. In this meta-analysis, we evaluated the impact of various HES generations on safety and efficacy endpoints in patients undergoing cardiac surgery. METHODS: We searched the PubMed, Embase and Cochrane Central Register of Controlled Trials databases for randomised controlled trials (RCTs) in the English or German language comparing the use of HES to any other colloid or crystalloid during open heart surgery. RESULTS: Blood loss and transfusion requirements were higher for older starches with mean molecular weights more than 200 kDa compared to other volume substitutes. In contrast, this effect was not observed with latest-generation tetrastarches (130/0.4), which performed even better when compared to albumin (blood loss of tetrastarch versus albumin: standardised mean difference (SMD), −0.34; 95% CI, −0.63, −0.05; P = 0.02; versus gelatin: SMD, −0.06; 95% CI, −0.20, 0.08; P = 0.39; versus crystalloids: SMD, −0.05; 95% CI, −0.20, 0.10; P = 0.54). Similar results were found for transfusion needs. Lengths of stay in the intensive care unit or hospital were significantly shorter with tetrastarches compared to gelatin (intensive care unit: SMD, −0.10; 95% CI, −0.15, −0.05; P = 0.0002) and crystalloids (hospital: SMD, −0.52; 95% CI, −0.90, −0.14; P = 0.007). CONCLUSIONS: In this meta-analysis of RCTs, we could not identify safety issues with tetrastarches compared with other colloid or crystalloid solutions in terms of blood loss, transfusion requirements or hospital length of stay in patients undergoing cardiac surgery. The safety data on coagulation with older starches raise some issues that need to be addressed in future trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-014-0656-0) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-04 2014 /pmc/articles/PMC4301454/ /pubmed/25475406 http://dx.doi.org/10.1186/s13054-014-0656-0 Text en © Jacob et al.; licensee BioMed Central. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jacob, Matthias
Fellahi, Jean-Luc
Chappell, Daniel
Kurz, Andrea
The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title_full The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title_fullStr The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title_full_unstemmed The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title_short The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
title_sort impact of hydroxyethyl starches in cardiac surgery: a meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301454/
https://www.ncbi.nlm.nih.gov/pubmed/25475406
http://dx.doi.org/10.1186/s13054-014-0656-0
work_keys_str_mv AT jacobmatthias theimpactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT fellahijeanluc theimpactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT chappelldaniel theimpactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT kurzandrea theimpactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT jacobmatthias impactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT fellahijeanluc impactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT chappelldaniel impactofhydroxyethylstarchesincardiacsurgeryametaanalysis
AT kurzandrea impactofhydroxyethylstarchesincardiacsurgeryametaanalysis